VEGFA and colorectal carcinoma: Such treatments can alter the protein expression of Bax, caspases, Bcl-2, MAPK, NF-κB, VEGF, DNA methylation, and CDK inhibitor and induce changes in the cell cycle and the CRC cellular functions of adhesion, migration, and invasion.